Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
SLS
VRDN
Add up to 3 more stocks
SLS
SELLAS Life Sciences Group, Inc.
-2.49%
$11.34-0.29Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$2.11B
52W Range
$1.39 - $15.88
VRDN
Viridian Therapeutics, Inc.
-4.11%
$18.22-0.78Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$2.06B
52W Range
$13.18 - $34.29
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 15.33 | 3.66 |
| P/S Ratio | N/A | 29.02 |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 0.0% | 99.5% |
| Operating Margin | 0.0% | -512.9% |
| Net Margin | 0.0% | -544.1% |
| ROE | -23.6% | -58.5% |
| ROA | -22.3% | -35.3% |
| ROIC | -25.4% | -39.2% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 18.83 | 16.95 |
| Quick Ratio | 18.83 | 16.95 |
| Debt/Equity | 0.01 | 0.37 |
| Interest Coverage | N/A | -73.44 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.